Raise HCE issue to DG GROW during EUCCC's Brussels Tour

2017-02-10 | All chapters

On behalf of HCE WG, IK got the opportunity to speak with the Policy Officer from EC DG GROW, and raised the key recommendation of HCE WG - Ensure Access of Patients to Medical Devices by Streamlining the Requirements to Clinical Trials. The Officer mentioned they had requested dialogues for both Cosmetics and HCE with CFDA for this spring. If the dialogues don't happen earlier, they are planning to see CFDA latest in Sept/Oct, when they come to Beijing for the AQSIQ dialogue.